Oops! 6 Holiday Costs We Forget to Budget For
How to Make Raising Kids Less Expensive
5 Reasons You'll Never Get Out of Debt
Last Week's Biggest Movers on Wall Street
Is Celgene the Perfect Stock?
Biotechnology company Celgene (CELG) announced it is buying Abraxis BioScience (ABII) for $2.9 billion in cash and stock. With this acquisition, Ceglene is expanding its portfolio of cancer treatments.